AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harry Stover who started this subject	6/29/2001 4:52:52 PM
From: John Romeo	Read Replies (1) of 513

6/29/01 Business Week article from Inside Wall Street Column has writer Gene Marcial mentioning AVAN is being eyed by major Pharmas MRK,PFE,BMY for possible licensing, development deal for its Cholesterol Vaccine. Writer mentioned this is a $4billion market. Stock up as high as 31% or $6.50 closing at 5.95 up 21% on the day. Many subscribers recieve their BW issue in Friday's mail. I believe once weekend investors catch up with the news there may be some follow through on Monday. Any Comments? This company is starting to near critical mass, let's get this thread going again. JR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next